Affimed to Present at the Jefferies 2017 Global Healthcare Conference - New York
May 30, 2017 09:01 am UTC| Business
Heidelberg, Germany, May 30, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi Hoess,...
Affimed to Present at the Jefferies 2017 Global Healthcare Conference - New York
May 30, 2017 09:01 am UTC| Business
Heidelberg, Germany, May 30, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi Hoess,...
May 30, 2017 08:56 am UTC| Business
Dublin, May 30, 2017 -- Research and Markets has announced the addition of the "Biosimilars Market Access in the U.S." report to their offering. The route to a formal US regulatory...
May 30, 2017 08:56 am UTC| Business
Dublin, May 30, 2017 -- Research and Markets has announced the addition of the "Biosimilars Market Access in the U.S." report to their offering. The route to a formal US regulatory...
Big Pharma Licensing Trends, 2012-2016 - Over 1,200 Drug-Focused Deals
May 30, 2017 08:55 am UTC| Business
Dublin, May 30, 2017 -- Research and Markets has announced the addition of the "Big Pharma Licensing Trends, 2012-16" report to their offering. Big Pharma Licensing Trends,...
May 30, 2017 08:52 am UTC| Business
Dublin, May 30, 2017 -- Research and Markets has announced the addition of the "Osteoporosis Market and Forecast Analysis" report to their offering. Osteoporosis is the most common...
United States & European Biosimilar Insulin Market Access Report 2017
May 30, 2017 08:51 am UTC| Business
Dublin, May 30, 2017 -- Research and Markets has announced the addition of the "Biosimilar Insulin Market Access" report to their offering. Biosimilar competition is providing...